The number of circulating endothelial cells and their progenitors is increased in some types of cancer, and there is evidence that aspects of these cells might correlate with clinical outcome of cancer patients treated with anti-angiogenic drugs.
- Francesco Bertolini
- Yuval Shaked
- Robert S. Kerbel